18. März 2024 - 22. März 2024
Université Paris-Saclay (France),
AFPT-Le Club Phase 1/EUFEMED/Université Paris-Saclay course: “Pre-Clinical and Clinical Safety in Early Development Human Trials”
VENUE
UNIVERSITÉ PARIS-SACLAY SITE HENRI MOISSAN
PÔLE BIOLOGIE-PHARMACIE CHIMIE 17 avenue des Sciences
91400 Saclay
FRANCE
PROGRAMME, REGISTRATION
This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. The training of several days provides a concise overview on safety in Human Pharmacology / Translational Medicine spanning from non-clinical pharmacology and toxicology over first-in-man to proof-of-concept clinical trials.
Coordinator: Dr Henri Caplain, President AFPT-Club Phase 1 Association française de pharmacologie translationnelle
Course exclusively in English and in presential due to its interactive nature. Some parts of the course could be performed on-line. Minimum number of participants: 10
